BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32918528)

  • 1. Cancer cachexia in a mouse model of oxidative stress.
    Brown JL; Lawrence MM; Ahn B; Kneis P; Piekarz KM; Qaisar R; Ranjit R; Bian J; Pharaoh G; Brown C; Peelor FF; Kinter MT; Miller BF; Richardson A; Van Remmen H
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1688-1704. PubMed ID: 32918528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia.
    Ahn B; Ranjit R; Kneis P; Xu H; Piekarz KM; Freeman WM; Kinter M; Richardson A; Ran Q; Brooks SV; Van Remmen H
    Aging Cell; 2022 Mar; 21(3):e13569. PubMed ID: 35199907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia.
    Xu H; Ranjit R; Richardson A; Van Remmen H
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1582-1596. PubMed ID: 34559475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of sarcopenia phenotypes by glutathione peroxidase 4 overexpression in mice.
    Xu H; Czyżowska A; Van Remmen H; Brown JL
    J Physiol; 2023 Dec; 601(23):5277-5293. PubMed ID: 37878529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated sarcopenia in Cu/Zn superoxide dismutase knockout mice.
    Deepa SS; Van Remmen H; Brooks SV; Faulkner JA; Larkin L; McArdle A; Jackson MJ; Vasilaki A; Richardson A
    Free Radic Biol Med; 2019 Feb; 132():19-23. PubMed ID: 30670156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
    Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senolytic treatment does not mitigate oxidative stress-induced muscle atrophy but improves muscle force generation in CuZn superoxide dismutase knockout mice.
    Borowik AK; Lawrence MM; Peelor FF; Piekarz KM; Crosswhite A; Richardson A; Miller BF; Van Remmen H; Brown JL
    Geroscience; 2024 Jun; 46(3):3219-3233. PubMed ID: 38233728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of
    Pollock N; Macpherson PC; Staunton CA; Hemmings K; Davis CS; Owen ED; Vasilaki A; Van Remmen H; Richardson A; McArdle A; Brooks SV; Jackson MJ
    eNeuro; 2023 Mar; 10(3):. PubMed ID: 36810149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.
    Morena da Silva F; Rosa-Caldwell ME; Schrems ER; Martinez L; Amos MG; Lim S; Cabrera AR; Brown JL; Washington TA; Greene NP
    Appl Physiol Nutr Metab; 2022 Sep; 47(9):933-948. PubMed ID: 35700525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated decline in cognition in a mouse model of increased oxidative stress.
    Logan S; Royce GH; Owen D; Farley J; Ranjo-Bishop M; Sonntag WE; Deepa SS
    Geroscience; 2019 Oct; 41(5):591-607. PubMed ID: 31641924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
    Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.
    Brown JL; Lee DE; Rosa-Caldwell ME; Brown LA; Perry RA; Haynie WS; Huseman K; Sataranatarajan K; Van Remmen H; Washington TA; Wiggs MP; Greene NP
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):987-1002. PubMed ID: 30328290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
    Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
    Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype.
    Sataranatarajan K; Qaisar R; Davis C; Sakellariou GK; Vasilaki A; Zhang Y; Liu Y; Bhaskaran S; McArdle A; Jackson M; Brooks SV; Richardson A; Van Remmen H
    Redox Biol; 2015 Aug; 5():140-148. PubMed ID: 25917273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REDD1 deletion attenuates cancer cachexia in mice.
    Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
    J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-Onset Physical Inactivity and Metabolic Dysfunction in Tumor-bearing Mice Is Associated with Accelerated Cachexia.
    Counts BR; Halle JL; Carson JA
    Med Sci Sports Exerc; 2022 Jan; 54(1):77-88. PubMed ID: 34431825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mouse model of frailty: the Cu/Zn superoxide dismutase knockout mouse.
    Deepa SS; Bhaskaran S; Espinoza S; Brooks SV; McArdle A; Jackson MJ; Van Remmen H; Richardson A
    Geroscience; 2017 Apr; 39(2):187-198. PubMed ID: 28409332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific deletion of CuZnSOD leads to an advanced sarcopenic phenotype in older mice.
    Bhaskaran S; Pollock N; C Macpherson P; Ahn B; Piekarz KM; Staunton CA; Brown JL; Qaisar R; Vasilaki A; Richardson A; McArdle A; Jackson MJ; Brooks SV; Van Remmen H
    Aging Cell; 2020 Oct; 19(10):e13225. PubMed ID: 32886862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.